32 Stocks Moving in Tuesday's Pre-Market Session

Author: Lisa Levin | May 12, 2020 07:16am

Gainers

• CymaBay Therapeutics, Inc. (NASDAQ:CBAY) shares rose 143.5% to $4.48 in pre-market trading after the company announced an independent expert panel unanimously concluded there is no evidence of liver injury in the Phase 2b NASH study of seladelpar. The panel supported re-initiating development of seladelpar. The company also reported narrower-than-expected Q1 loss. Raymond James and Evercore ISI Group upgraded CymaBay Therapeutics to Outperform.
• Gamida Cell Ltd. (NASDAQ:GMDA) rose 89.4% to $8.60 in pre-market trading after the company reported positive topline data from Phase 3 clinical study of Omidubicel in patients with high-risk hematologic malignancies.
• American Outdoor Brands Corporation (NASDAQ:AOBC) rose 45.2% to $15.11 in pre-market trading.
• Akorn, Inc. (NASDAQ:AKRX) rose 39.4% to $0.3550 in pre-market trading following Q1 results. Akorn posted Q1 earnings of $0.36 per share, versus a year-ago loss of $0.10 per share.
• Novavax, Inc. (NASDAQ:NVAX) rose 34.5% to $32.96 in pre-market trading after the company reported better-than-expected Q1 results. The company also announced it will receive up to $388 million in funding from CEPI for COVID-19 (coronavirus) vaccine development and manufacturing.
• Fluent, Inc. (NASDAQ:FLNT) rose 32.1% to $3.00 in pre-market trading following better-than-expected Q1 results.
• II-VI, Inc. (NASDAQ:IIVI) rose 27% to $46.00 in pre-market trading after the company reported better-than-expected Q3 sales.
• YRC Worldwide Inc. (NASDAQ:YRCW) rose 25.7% to $1.86 in pre-market trading after the company reported better-than-expected Q1 results.
• MicroVision, Inc. (NASDAQ:MVIS) shares rose 25.2% to $1.05 in pre-market trading as traders circulate an unknown source article from Florida Independent titled 'Microsoft's Acquisition of Microvision Confirmed.'
• NanoViricides Inc (NYSE:NNVC) rose 19.8% to $8.52 in pre-market trading after the company developed highly effective broad-spectrum drug candidates against coronaviruses.
• Chaparral Energy, Inc. (NYSE:CHAP) rose 18.2% to $0.5081 in pre-market trading following Q1 results. Chaparral Energy reported Q1 EPS of $0.23.
• MacroGenics, Inc. (NASDAQ:MGNX) rose 16.2% to $30.58 in pre-market trading after surging over 29% on Monday.
• Brighthouse Financial Inc (NASDAQ:BHF) rose 14% to $32.00 in pre-market trading after the company reported better-than-expected Q1 earnings.
• Invesco Mortgage Capital Inc. (NYSE:IVR) rose 11.5% to $2.91 in pre-market trading after the company reported common and preferred stock dividend payment dates.
• International Flavors & Fragrances Inc. (NYSE:IFF) rose 8.4% to $143.70 in pre-market trading after the company reported better-than-expected Q1 results.
• AMC Entertainment Holdings, Inc. (NYSE:AMC) rose 7.1% to $5.70 in pre-market trading after jumping around 30% on Monday.
• Grocery Outlet Holding Corp (NASDAQ:GO) rose 5% to $38.50 in pre-market trading after the company reported better-than-expected Q1 results and comparable store sales up 17.4%.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Genfit SA (NASDAQ:GNFT) fell 63.2% to $7.98 in pre-market trading after the company disclosed results from an interim study of RESOLVE-IT Phase 3 trial.
• Rand Capital Corporation (NASDAQ:RAND) shares fell 31.1% to $2.06 in pre-market trading. Rand Capital shares climbed 8% on Monday after the company reported Q1 results.
• Advanced Emissions Solutions, Inc. (NASDAQ:ADES) fell 25.2% to $5.80 in pre-market trading after reporting Q1 results. Advanced Emissions Solutions posted a Q1 loss of $0.11 per share.
• California Resources Corporation (NYSE:CRC) fell 23.4% to $1.86 in pre-market trading.
• Nabriva Therapeutics plc (NASDAQ:NBRV) fell 11% to $0.65 in pre-market trading after the company reported wider-than-expected Q1 loss.
• Eventbrite Inc (NYSE:EB) shares fell 10.7% to $9.40 in pre-market trading after the company reported worse-than-expected Q1 results.
• Marker Therapeutics, Inc. (NASDAQ:MRKR) fell 10.1% to $2.23 in pre-market trading following downbeat Q1 earnings. Piper Sandler downgraded Marker Therapeutics from Overweight to Neutral and lowered the price target from $5 to $2.5.
• AgEagle Aerial Systems, Inc. (NYSE:UAVS) fell 9.4% to $1.34 in pre-market trading after surging around 40% on Monday.
• Genius Brands International, Inc. (NASDAQ:GNUS) fell 9.3% to $0.73 in pre-market trading after jumping 39% on Monday.
• DBV Technologies S.A. (NASDAQ:DBVT) shares fell 8.6% to $5.63 in pre-market trading.
• CPS Technologies Corporation (NASDAQ:CPSH) fell 8.5% to $1.40 in pre-market trading after rising around 9% on Monday.
• Halozyme Therapeutics, Inc. (NASDAQ:HALO) fell 7.3% to $23.00 in pre-market trading after the company reported worse-than-expected Q1 results.
• Akebia Therapeutics, Inc. (NASDAQ:AKBA) fell 6.6% to $12.00 in pre-market trading after the company announced a proposed $100 million public offering of common stock.
• The Chefs' Warehouse, Inc. (NASDAQ:CHEF) fell 6% to $13.75 in pre-market trading after the company reported a proposed public offering of common stock.
• Tencent Music Entertainment Group - ADR (NYSE:TME) fell 4.3% to $10.92 in pre-market trading after the company reported worse-than-expected Q1 results.

Posted In: ADES AKBA AKRX AMC AOBC BHF CBAY CHAP CHEF CPSH CRC DBVT EB FLNT GMDA GNFT GNUS GO HALO IFF